Midazolam Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Midazolam Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 04/02/2020. Reported reason: Delay in shipping of the drug
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-411-10
- Dosage Form
- Injection
- Presentation
- Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10)
- Initial Posting
- 04/02/2020
- Revised Date
Reason
Delay in shipping of the drug